PharmaNanoGene: Farmacocinética, Nanotecnología y Terapia Génica
Universidad de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Navarra (7)
2020
2018
-
Population pharmacokinetics of daptomycin in critically ill patients
International Journal of Antimicrobial Agents, Vol. 52, Núm. 2, pp. 158-165
2015
-
Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: Model-based evaluation of standard dosing regimens
International Journal of Antimicrobial Agents, Vol. 45, Núm. 5, pp. 504-511
2014
-
Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: Application to pharmacokinetic/pharmacodynamic analysis
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 1, pp. 180-189
2012
-
Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery
European Journal of Clinical Pharmacology, Vol. 68, Núm. 5, pp. 735-745
2011
-
Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 3, pp. 167-173
2008
-
Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy
Clinical Pharmacokinetics, Vol. 47, Núm. 3, pp. 173-180